US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to
The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna’s Covid vaccine. The bird flu shot
Shares of Moderna fell as much as 4% when US markets opened on Thursday. The company didn’t respond to a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
